A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-23) →
What happened
AprilBio's controlling stake is set to change hands, in a deal worth US$97M.
A change of the controlling shareholder can reshape a company's strategy, capital allocation, and board.
| Deal value | US$97M |
|---|---|
| Filed | 2026-06-25, Agreement on change of control signed |
| Source | DART rcept 20260625900002 → open original filing |
Versions of this filing
- 2026-06-25Original (this page)
- 2026-07-23Amendment 1
Source: DART. Information only, not investment advice.